Matthias Gromeier

11PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Innate immunityMedical molecular engineering of nucleic acids and proteinsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 16, 2026
EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial.

|Apr 17, 2026
Viral Microglia Reprogramming Clears Oligomeric Neurotoxic Debris.

|Nov 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.

Andrea L Ludwig, Zachary P McKay, Griffin P Carter

|Jul 08, 2025
Polio virotherapy provokes MDA5 signaling and CD4+ T cell help to mediate cancer in situ vaccination.

Matthias Gromeier, Michael C Brown

|Nov 14, 2023
Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling.

Mikhail I Dobrikov, Elena Y Dobrikova, Dasean T Nardone-White

|Jun 02, 2022
PKR Binds Enterovirus IRESs, Displaces Host Translation Factors, and Impairs Viral Translation to Enable Innate Antiviral Signaling.

Mikhail I Dobrikov, Elena Y Dobrikova, Zachary P McKay

Pageof 2

Frequent Collaborators

7 joint publications

Michael C Brown

4 joint publications

Smita K Nair

3 joint publications

Jonathan P Kastan

2 joint publications

Griffin P Carter